- Multiple myeloma
- Advanced breast cancer
- Advanced ovarian cancer
- Polycythemia vera
MELFALAX 2MG
| MRP | : |
|
| Price | : | ₹2,480.00 |
| You Save | : | ₹655.00 (20.89%) |
25 Tablet(s) In A Bottle
Melfalax 2mg tablet contains Melphalan as its active ingredient. This medication is classified as an anticancer agent and falls under the category of alkylating agents. It is utilized in the treatment of multiple myeloma, which is a type of bone marrow cancer. Additionally, it is prescribed for advanced breast and ovarian cancer. Furthermore, it is indicated for the treatment of polycythemia vera, a condition that leads to an increased number of red blood cells, resulting in thicker blood and a higher risk of blood clots. The medication functions by decreasing the production of abnormal cells in the body.
Do not use Melfalax 2mg tablet if you have an allergy to melphalan or any of its other components. Notify your doctor if you have recently undergone radiotherapy or chemotherapy, or if you have any kidney issues. This medication should not be taken if you are pregnant or planning to become pregnant. Inform your healthcare provider if you have received a vaccination recently or are planning to get vaccinated. If you experience a rash, lumps, or hives on your skin, swelling of the face, eyelids, or lips, or sudden wheezing and chest tightness after taking this medication, contact your physician immediately.
